ESC 365 - Rivaroxaban attenuates valvular inflammation and tissue remodeling in patients with severe aortic stenosis

ESC Premium Access

Rivaroxaban attenuates valvular inflammation and tissue remodeling in patients with severe aortic stenosis

Session: Valvular heart disease and infective endocarditis e-posters

Topic: Aortic Valve Stenosis

Speaker: Ms M. Kopytek (Krakow, PL)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Ms Magdalena Kopytek

John Paul II Hospital, Krakow (Poland)

0 follower

130 more presentations in this session

Clinical and echocardiographic characteristics associated with the development of infective endocarditis in patients with significant mitral stenosis

Speaker: Doctor N. Ngiam (Singapore, SG)

Local or general anesthesia for TAVI surgery? An updated systematic review and meta-analysis.

Speaker: Doctor Z. Cheng (Chengdu, CN)

Use of left ventricular support devices during transcatheter aortic valve replacement and balloon aortic valvuloplasty: a single center experience

Speaker: Doctor S. Mahmood (Detroit, US)

Left atrial dynamics in the hemodynamic response during exercise in patients with asymptomatic severe aortic stenosis

Speaker: Doctor T. Sugimoto (Nagoya, JP)

Impact of mitral valve regurgitation severity on clinical outcomes in patients with severe aortic stenosis undergoing TAVI

Speaker: Doctor V. Jimenez Franco (Madrid, ES)

Access the full session

Valvular heart disease and infective endocarditis e-posters

Speakers: Ms M. Kopytek, Doctor N. Ngiam, Doctor Z. Cheng, Doctor S. Mahmood, Doctor T. Sugimoto...

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources